CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
Study Number | Lead Group | Study Title | CIRB | Study Status |
---|---|---|---|---|
UAZ20-01-01 | CP-CTNet_CLO-University of Arizona | Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy | Cancer Prevention and Control CIRB | Available to Open |
UAZ2016-08-02 | CP-CTNet_CLO-University of Arizona | A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions | Cancer Prevention and Control CIRB | Available to Open |
UAZ20-01-02 | CP-CTNet_CLO-University of Arizona | An extended follow-up study of the HPV vaccine delayed booster trial | Cancer Prevention and Control CIRB | Available to Open |
UAZ2015-05-01 | CP-CTNet_CLO-University of Arizona | A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys | Cancer Prevention and Control CIRB | Available to Open |
UAZ2015-05-02 | CP-CTNet_CLO-University of Arizona | M4OC-Prevent: Metformin for Oral Cancer Prevention | Cancer Prevention and Control CIRB | Completed |
NWU20-02-01 | CLO-Northwestern University | Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia | Cancer Prevention and Control CIRB | Available to Open |
NWU2016-08-02 | CLO-Northwestern University | A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis | Cancer Prevention and Control CIRB | Available to Open |
NWU20-02-02 | CLO-Northwestern University | A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open |
NWU2015-06-02 | CLO-Northwestern University | Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial | Cancer Prevention and Control CIRB | Available to Open |
NWU20-04-01 | CLO-Northwestern University | Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals | Cancer Prevention and Control CIRB | Available to Open |